drugset / Trial / NCT01828359

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

NCT01828359

Phase 4 Completed 199 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the blood pressure lowering effects of an amlodipine/losartan combination treatment and losartan/Hydrochlorothiazide combination treatment in patients with essential hypertension uncontrolled with losartan 100mg monotherapy.

Timeline

Start
2010-08
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Comparator Hydrochlorothiazide Unknown 12.5 mg
Background Losartan Other / unclassified 100 mg